DEVARTLab Announces Strategic
Partnerships with American Companies to Enhance Egyptian and Middle Eastern
Markets
In light of the strategic partnership signed
with the CH Group and Abu Dhabi Ports Group.
and within the framework of enhancing the
position of global companies and emphasizing the importance of Middle Eastern
markets, especially the Egyptian market, and according to the Egyptian state’s
plans aimed at attracting foreign investment, DEVARTLab Group announced the
signing of several partnership and distribution agreements with a number of
major American companies under the umbrella of the global CH Group.
These strategic partnerships cover various
fields such as pharmaceuticals, nutritional supplements, medical devices,
cosmetics, therapeutic products, and veterinary products. Through these
partnerships, expertise and advanced technology from American companies will be
transferred to Egypt, which will contribute to raising the quality level of
products in the Egyptian and Middle Eastern markets.
These partnerships highlight the immense
capabilities of DEVARTLab in expanding in the Egyptian and Middle Eastern
markets in the distribution of products from major global companies, being the
leading company in the pharmaceutical and nutritional supplements sector.
Among
these companies are:
CH GROUP: https://chgroupus.com/
AD Ports: https://adportsgroup.com/en
Exotropin: http://www.exoceuticals.com/
NUMEDICO: http://www.numedico.com/
MHP | Maximum Human Performance: https://mhpstrong.com/
MUSCLEMEDS: https://musclemedsrx.com/
WINDMILL: http://www.windmillvitamins.com/
Avertix: https://avertix.com/
Green Gruff: http://www.greengruff.com/
Roofa: https://roofaspain.com/en/mom-baby/basic-care
EYE POINT PHARMACEUTICALS: https://eyepointpharma.com/technology/#sec-voro
Osmotica Pharmaceuticals: https://eyepointpharma.com/technology/#sec-voro
Scilex: http://www.scilexholding.com/
Rapha Pharmaceuticals: https://raphapharma.com/
These companies operate in the fields of
healthcare, providing nutritional supplements, minerals, vitamins, supplements
for athletes, as well as medical cosmetic products, veterinary products,
skincare and general health products, and pharmaceutical products targeting
various diseases. Additionally, they offer the latest technologies in different
medical devices.
These partnerships represent an important step
towards enhancing innovation and expanding investments in the Egyptian market
and Middle Eastern markets, strengthening the position of DEVARTLab as a
leading company in this field.
Press Release on CH Group Website:
